FILE PHOTO: A injection pen of Novo Nordisk’s weight-loss drug

FILE PHOTO: A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo

Post navigation

Previous: Novo valuation surpasses Tesla on experimental obesity drug data

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

Search

You may have missed

2025-12-20T214131Z_1_LYNXMPELBJ0BQ_RTROPTP_4_ROCHE-HLDG-CANCER-PILL.JPG

2 minutes read

Newsletters

Roche CEO points to higher future drug prices in Switzerland after US deal

Bull Bear Daily December 22, 2025 0

2025-12-22T140835Z_1_LYNXMPELBL0LK_RTROPTP_4_TRAVEL-CM-SHANGHAI.JPG

3 minutes read

Newsletters

China economy grew below 3% in 2025, half of official target, think tank estimates

Bull Bear Daily December 22, 2025 0

2025-12-19T134618Z_1_LYNXMPELBI0X7_RTROPTP_4_GLOBAL-METALS-COPPER.JPG

2 minutes read

Newsletters

Copper nears record high as supply tightness back in focus

Bull Bear Daily December 21, 2025 0

3 minutes read

Newsletters

Compass-Anywhere brokerage deal would hurt homebuyers, US Senators say

Bull Bear Daily December 20, 2025 0

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us